Al
Allergan (AbbVie)
Dublin IEFounded 195017,000 employees
Private CappharmaAcquiredOphthalmologyDermatology
Platform: Botox
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ALL-5401 | ALL-5401 | NDA/BLA | 2 | CGRP | DMD | ||
| Mirilemzoparlimab | ALL-3766 | Phase 2 | 1 | CD20 | MDDGA | ||
| Elrazumab | ALL-2232 | NDA/BLA | 1 | CD3 | CMLPancreatic Ca |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (5)